Zura Bio Limited
ZURA
$5.78
-$0.35-5.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -19.88% | 44.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.99% | 38.50% | |||
| Operating Income | -14.99% | -38.50% | |||
| Income Before Tax | -8.93% | -41.04% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.59% | -41.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.59% | -41.04% | |||
| EBIT | -14.99% | -38.50% | |||
| EBITDA | -15.00% | -38.52% | |||
| EPS Basic | 3.89% | 55.40% | |||
| Normalized Basic EPS | 3.63% | -19.17% | |||
| EPS Diluted | 3.89% | 55.40% | |||
| Normalized Diluted EPS | 3.63% | -19.17% | |||
| Average Basic Shares Outstanding | 12.99% | 18.36% | |||
| Average Diluted Shares Outstanding | 12.99% | 18.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||